Disrupting the orthopedic industry with laser technology

Disrupting the orthopedic industry with laser technology.

The orthopedic industry has been continually evolving to find more effective, opioid-free ways to treat pain. Laser therapy has emerged as a leading method for pain relief, offering a non-invasive solution that can significantly improve patient outcomes. The spotlight is on how laser technology is revolutionizing pain management, promising a future where patients can experience relief without the dangers involved with opioids.

Revolutionizing Orthopedic Treatment

Laser therapy has gained traction in pain management due to its advanced capabilities. Therapy lasers work by emitting specific wavelengths of light that penetrate tissues, promoting cellular regeneration and reducing inflammation.

The most innovative laser solution is the MLS-M8 Robotic Therapy Laser. This exclusive technology from OrthoLazer is FDA-cleared and utilizes patented technology to ensure safe and highly effective pain treatment. Unlike traditional lasers that are not as effective and may be uncomfortable, the MLS-M8 is fully automated and ensures a painless experience for patients.

The MLS-M8’s precision allows it to target affected areas without damaging surrounding tissues, making it ideal for treating a variety of orthopedic conditions.

Benefits for Patients

One of the significant advantages of the MLS-M8 Robotic Therapy Laser is its ability to provide an opioid-free alternative for effectively managing both acute and chronic orthopedic pain. This alternative is crucial in combating the opioid crisis, offering patients a safer path to recovery.

The MLS-M8 is effective across a wide range of conditions, from tennis elbow to plantar fasciitis. Patients often report substantial pain relief and improved range of motion after just a few sessions. Treatment times are remarkably short, generally between 4 to 12 minutes, which means patients can easily fit sessions into their busy schedules without experiencing downtime.

Moreover, the cumulative effects of the MLS-M8 on pain and inflammation often reduce the need for opioids post-surgery, a significant step forward in pain management. The American Academy of Orthopaedic Surgeons (AAOS) and the Centers for Disease Control and Prevention (CDC) recognize laser therapy as a recommended treatment for managing pain, underscoring its clinical credibility.

Setting New Standards

The MLS-M8 has proven particularly effective in treating stubborn conditions such as IT band tendinitis and meniscal tears. Its targeted approach ensures patients receive precise treatment tailored to their specific needs.

Furthermore, the MLS-M8 delivers cumulative effects, meaning that patients experience progressively better results with each session. This feature is especially beneficial for managing chronic conditions, where ongoing treatment is necessary to maintain a high quality of life.

A Unique Franchise Opportunity

OrthoLazer’s commitment to providing non-invasive, opioid-free alternatives for pain relief extends beyond patient care. The organization offers a unique business opportunity for orthopedic surgeons to generate ancillary income through their “business-in-a-box” franchise model. This franchise model simplifies the process of opening an OrthoLazer Center, providing comprehensive support from initial setup to ongoing marketing assistance and patient acquisition strategies.

Orthopedic surgeons, physicians, and other pain management specialists who want to improve patient care while also enhancing their revenue can explore this exciting opportunity. OrthoLazer’s franchise system ensures that our partners benefit from robust support, enabling them to deliver exceptional care to their communities.

To learn more about becoming an OrthoLazer franchise partner or to discuss how this advanced technology can benefit your community, visit our website or call 888.652.9199. 

OrthoLazer Orthopedic Laser Centers offer patients and their doctors an innovative and effective alternative pain management option to treat acute and chronic orthopedic conditions. Founded by Dr. Scott Sigman – the original opioid-sparing surgeon – our centers further his mission of providing his patients non-operative and non-opioid treatment options. If you’d like more information about OrthoLazer, please visit our website at

Share On:

Related Content